2. Oct 2026
Description
(AWP Alliance News) - Alcon announced results from an investigator-initiated, head-to-head clinical study showing its over-the-counter Systane Pro Preservative-Free delivered dry eye symptom relief comparable to prescription Miebo. The results were presented at the American Academy of Optometry 2026 Annual Meeting.
The trial met its main goal, supporting Systane Pro PF as a potential first-line option for patients, including those facing insurance or cost barriers to prescription therapy. The study enrolled 256 patients with moderate-to-severe dry eye symptoms and compared the two treatments over one month.
https://www.publicnow.com/view/72C238FB93EB75B544C140C4FF910C67975AADAF…
Disclaimer: This news brief was created using generative artificial intelligence. Alcon AG published the original content used to generate this news brief on October 02, 2026, and is solely responsible for the information contained therein.
